Baroreflex activation therapy for the treatment of heart failure with a reduced ejection fraction: safety and efficacy in patients with and without cardiac resynchronization therapy.
about
Baroreflex Activation Therapy in Heart Failure With Reduced Ejection Fraction: Available Data and Future Perspective.Autonomic, functional, skeletal muscle, and cardiac abnormalities are associated with increased ergoreflex sensitivity in mitochondrial disease.Acute Response to Unilateral Unipolar Electrical Carotid Sinus Stimulation in Patients With Resistant Arterial Hypertension.Electrical carotid sinus stimulation: chances and challenges in the management of treatment resistant arterial hypertension.Restoration of normal sympathetic neural function in heart failure following baroreflex activation therapy: final 43-month study report.Baroreflex Activation Therapy in Congestive Heart Failure: Novel Findings and Future Insights.NEUROMODULATION OF THE FAILING HEART: LOST IN TRANSLATION?Baroreflex activation therapy: a new approach to the management of advanced heart failure with reduced ejection fraction.Low-Level But Not High-Level Baroreceptor Stimulation Inhibits Atrial Fibrillation in a Pig Model of Sleep Apnea.Baroreceptors in the carotid and hypertension-systematic review and meta-analysis of the effects of baroreflex activation therapy on blood pressure.The autonomic nervous system as a therapeutic target in heart failure: a scientific position statement from the Translational Research Committee of the Heart Failure Association of the European Society of Cardiology.Treating cardiac dysrhythmias by targeting the neck: Off target or on the right track?[Baroreflex activation therapy. A novel interventional approach to treat heart failure with reduced ejection fraction].An early analysis of cost-utility of baroreflex activation therapy in advanced chronic heart failure in GermanyCalming the Nervous Heart: Autonomic Therapies in Heart Failure
P2860
Q31046062-A854EADA-464F-430A-A3A3-2C3673D50A2DQ31165571-488958A8-7585-470B-81C0-C550BE8CE899Q36638767-DEFB85AA-C40C-4BC0-9B47-A7350BF2DC0FQ38553738-101B75D7-3146-4FAD-B0F4-A66C0A8A8487Q38620423-D0CF1144-6DA1-43BA-8DE6-CD0BE2A6C803Q38849638-2EF0D290-548C-4A3F-92CF-8A45338EB815Q38927895-C7C2E470-8D82-4F8F-8738-4510B583F9BDQ39454168-971A6FC3-AA2E-419C-96DA-95FF759EA175Q47425968-C01B4FAC-3B24-4245-BE06-99B99A3419F2Q47599344-D34D4DDD-C775-42CB-B587-4F768AA1AA91Q47631903-5C8F28A3-8AE5-4C9C-B622-249837744FBEQ48285083-B8499A4D-4D04-40C5-ADD8-6CD765405EE7Q53658815-24BBAD09-5420-45F5-9B16-E8BC91D00E15Q58793587-5ACD166E-32A8-4E90-84EA-7A1F85592F97Q58804693-07FD79BF-C8C5-4124-BCFB-BF69F87423C6
P2860
Baroreflex activation therapy for the treatment of heart failure with a reduced ejection fraction: safety and efficacy in patients with and without cardiac resynchronization therapy.
description
2015 nî lūn-bûn
@nan
2015 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Baroreflex activation therapy ...... iac resynchronization therapy.
@ast
Baroreflex activation therapy ...... iac resynchronization therapy.
@en
Baroreflex activation therapy ...... iac resynchronization therapy.
@nl
type
label
Baroreflex activation therapy ...... iac resynchronization therapy.
@ast
Baroreflex activation therapy ...... iac resynchronization therapy.
@en
Baroreflex activation therapy ...... iac resynchronization therapy.
@nl
prefLabel
Baroreflex activation therapy ...... iac resynchronization therapy.
@ast
Baroreflex activation therapy ...... iac resynchronization therapy.
@en
Baroreflex activation therapy ...... iac resynchronization therapy.
@nl
P2093
P2860
P50
P356
P1476
Baroreflex activation therapy ...... diac resynchronization therapy
@en
P2093
Anique Ducharme
Christian Butter
Didier Klug
Eric G Lovett
Fred A Weaver
Jill E Schafer
Jochen Müller-Ehmsen
Marcel Halbach
Vijay Swarup
William C Little
P2860
P304
P356
10.1002/EJHF.299
P577
2015-06-10T00:00:00Z